LAUREN DEFARLO: Open Payments
NPI 1831656016 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$452 in 19 payments from 6 companies in 2025. Trend: 2023 $910 · 2024 $1,045 · 2025 $452
Food & beverage: $452
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $225 |
| Janssen Scientific Affairs, LLC | 1 | $85 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $82 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $29 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $15 |
| Madrigal Pharmaceuticals | 1 | $15 |
Products named: CREON, TREMFYA, XIFAXAN, LINZESS, ENTYVIO, JOURNAVX, REZDIFFRA, RINVOQ.
Industry payments across PA — which companies pay providers there.
